SCHEMBL23725581

SCHEMBL23725581

Cc1c(COC(=O)NCC(C)O)nc2cc(Br)ccn2c1=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.33
RXFP1 Q9HBX9 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KDM4E B2RXH2 4/20 0.33
POLB P06746 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
CFTR P13569 1/20 0.32
CYP3A4 P08684 1/20 0.32
PTGFR P43088 1/20 0.32
ALDH1A1 P00352 3/20 0.31
HPGD P15428 3/20 0.31
GLA P06280 1/20 0.31
HDAC1 Q13547 1/20 0.31
TP53 P04637 1/20 0.31
MAPK1 P28482 2/20 0.31
PSMB1 P20618 1/20 0.31
PSMB5 P28074 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23725609 0.86 CNR1 (0.35) GAARXFP1KDM4EPOLBL3MBTL1
SCHEMBL23725658 0.81 POLB (0.33) GAARXFP1NPSR1KDM4EPOLB
SCHEMBL23725655 0.81 POLB (0.33) GAARXFP1NPSR1KDM4EPOLB
SCHEMBL23726597 0.78 CD274 (0.36)
SCHEMBL25168873 0.77 ALDH1A1 (0.33) RXFP1ALDH1A1MAPK1MEN1KMT2A
SCHEMBL23725579 0.73 MEN1 (0.34) GAARXFP1KDM4EPOLBALDH1A1
SCHEMBL23725667 0.73 KDM4E (0.36) GAARXFP1KDM4EPOLBALDH1A1
SCHEMBL25664468 0.71 SSTR4 (0.35) HDAC1
SCHEMBL23725934 0.70 HDAC1 (0.34) RXFP1KDM4EPOLBALDH1A1HDAC1
SCHEMBL23726231 0.66 KDM4E (0.38) GAAKDM4EPOLBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL GAA 1601/4885RXFP1 3840/4885NPSR1 3724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.